C. Pasquinelli

发表

Hepatitis C Virus-specific Cytotoxic T Lymphocytes Restricted by HLA-A2 are Present in the Peripheral Blood of Patients with Chronic Hepatitis C

F. Chisari, M. Houghton, J. McHutchison, 1994 .

Frequent lymphocytes infection by hepatitis B virus in haemophiliacs

C. Bréchot, L. Chatenoud, C. Gazengel, 1987, British journal of haematology.

Hepatitis B virus DNA in mononuclear blood cells. A frequent event in hepatitis B surface antigen-positive and -negative patients with acute and chronic liver disease.

H. Bismuth, C. Bréchot, L. Chatenoud, 1986, Journal of hepatology.

1422 POTENT VIRAL SUPPRESSION WITH ALL-ORAL COMBINATION OF DACLATASVIR (NS5A INHIBITOR) AND GS-7977 (NS5B INHIBITOR), +/− RIBAVIRIN, IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GT1, 2, OR 3

A. Lok, K. Reddy, P. Thuluvath, 2012 .

Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice

R. Palmiter, F. Chisari, S. Sell, 1989, Cell.

Pharmacokinetics of the NS3 Protease Inhibitor, Asunaprevir (ASV, BMS‐650032), in Phase I Studies in Subjects With or Without Chronic Hepatitis C

A. D. Rodrigues, R. Bertz, D. Grasela, 2013, Clinical pharmacology in drug development.

Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection.

P. Marcellin, P. Thuluvath, G. Everson, 2014, Gastroenterology.

Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection.

A. Lok, K. Reddy, T. Hassanein, 2014, The New England journal of medicine.

Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders.

A. Lok, P. Marcellin, G. Everson, 2014, Journal of hepatology.

Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection.

F. Chisari, B. Rehermann, C. Pasquinelli, 1995, The Journal of clinical investigation.

Protection by diethyldioxystilbenedipropionate against leucopenia due to roentgen therapy

C. Pasquinelli, E. Lusvarghi, L. Bellesia, 1957 .

Hepatitis B virus persistence after recovery from acute viral hepatitis.

F. Chisari, S. Guilhot, C. Pasquinelli, 1994, The Journal of clinical investigation.

Alcohol and hepatitis B virus infection.

E. Villa, D. Braghiroli, C. Pasquinelli, 2009, Acta medica Scandinavica. Supplementum.

Hepatitis B virus infection of peripheral blood mononuclear cells is common in acute and chronic hepatitis

M. Melegari, E. Villa, C. Pasquinelli, 1990, Journal of medical virology.

The hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice

F. Chisari, C. Rogler, L. Guidotti, 1996, Journal of virology.

Rearrangement of a common cellular DNA domain on chromosome 4 in human primary liver tumors

K. Grzeschik, L. Bougueleret, C. Bréchot, 1988, Journal of virology.

Preliminary study of two antiviral agents for hepatitis C genotype 1.

Anna Persson, Vinod Rustgi, A. Lok, 2012, The New England journal of medicine.

Ethanol‐induced increase in cytosolic estrogen receptors in human male liver: A possible explanation for biochemical feminization in chronic liver disease due to alcohol

G. Rossini, S. Bellentani, M. Melegari, 1988, Hepatology.

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T–lymphocyte response

F. Chisari, B. Rehermann, C. Ferrari, 1996, Nature Medicine.

Risk factors for hepatocellular carcinoma in italy. Male sex, hepatitis b virus, non‐a non‐B infection, and alcohol

M. Melegari, E. Cariani, E. Villa, 1988, Cancer.

Detection of mononuclear cells expressing hepatitis B virus in peripheral blood from HBsAg positive and negative patients by in situ hybridisation

C. Bréchot, M. Hadchouel, J. Fournier, 1988, Journal of medical virology.

1356 QUADRUPLE THERAPY WITH BMS-790052, BMS-650032 AND PEG-IFN/RBV FOR 24 WEEKS RESULTS IN 100% SVR12 IN HCV GENOTYPE 1 NULL RESPONDERS

A. Lok, G. Everson, D. Grasela, 2011 .

Randomized, Placebo-Controlled, Single-Ascending-Dose Study of BMS-791325, a Hepatitis C Virus (HCV) NS5B Polymerase Inhibitor, in HCV Genotype 1 Infection

P. Tebas, J. Lemm, D. Grasela, 2014, Antimicrobial Agents and Chemotherapy.

Hepatitis B virus specific transcripts in peripheral blood mononuclear cells.

M. Melegari, E. Villa, C. Pasquinelli, 1992, Archives of virology. Supplementum.

Hepatitis C virus core and E2 protein expression in transgenic mice

F. Chisari, M. Houghton, J. Chung, 1997, Hepatology.

[HBV DNA in mononuclear cells of peripheral blood in acute hepatitis B: a comparative analysis of Southern blot and polymerase chain reaction (PCR)].

M. Melegari, C. Pasquinelli, P. Scaglioni, 1990, Medicina.

Significance of anti‐HBx antibodies in hepatitis B virus infection

M. Perricaudet, V. Barnaba, A. Alberti, 1991, Hepatology.

Resistance Analysis of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir

Chaoqun Chen, P. Falk, A. Sheaffer, 2012, Antimicrobial Agents and Chemotherapy.

Single- and Multiple-Ascending-Dose Studies of the NS3 Protease Inhibitor Asunaprevir in Subjects with or without Chronic Hepatitis C

W. Kraft, D. Grasela, A. Persson, 2012, Antimicrobial Agents and Chemotherapy.

Detection of hepatitis B virus transcripts in patients with chronic liver disease.

C. Tiribelli, M. Melegari, L. Crocè, 1990, Journal of hepatology.

Hepatocarcinogenesis in Hepatitis B Virus Transgenic Mice Structurally and Functionally Intact during Multiple Oncogenes and Tumor Suppressor Genes Are Updated

Bhavani, F. Chisari, C. Pasquinelli, 2006 .

Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice.

F. Chisari, F V Chisari, C Pasquinelli, 1992, Cancer research.

A Cell-Based Model of HCV-Negative-Strand RNA Replication Utilizing a Chimeric Hepatitis C Virus/Reporter RNA Template

M. Jeffries, R. King, C. Pasquinelli, 2002, Antiviral chemistry & chemotherapy.

Single-and Multiple-Ascending-Dose Studies of the NS 3 Protease Inhibitor Asunaprevir in Subjects with or without Chronic Hepatitis C

W. Kraft, A. Persson, T. Marbury, 2012 .

Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus.

A. Sette, F. Chisari, Kyong‐Mi Chang, 1997, The Journal of clinical investigation.

Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.

F. Chisari, M. Houghton, M. A. Brothers, 1995, The Journal of clinical investigation.

The Effect of Hepatic Impairment on the Pharmacokinetics of Asunaprevir, an HCV NS3 Protease Inhibitor

R. Bertz, T. Marbury, T. Eley, 2015, Antiviral therapy.

1423 INTERIM ANALYSIS OF AN INTERFERON (IFN)- AND RIBAVIRIN (RBV)-FREE REGIMEN OF DACLATASVIR (DCV), ASUNAPREVIR (ASV), AND BMS-791325 IN TREATMENT-NAIVE, HEPATITIS C VIRUS GENOTYPE 1-INFECTED PATIENTS

P. Marcellin, P. Thuluvath, G. Everson, 2013 .

1417 SUSTAINED VIROLOGIC RESPONSE WITH DACLATASVIR PLUS SOFOSBUVIR ± RIBAVIRIN (RBV) IN CHRONIC HCV GENOTYPE (GT) 1-INFECTED PATIENTS WHO PREVIOUSLY FAILED TELAPREVIR (TVR) OR BOCEPREVIR (BOC)

A. Lok, K. Reddy, T. Hassanein, 2013 .

[Estrogen receptors in the human liver].

M. Melegari, C. Pasquinelli, G. Baldini, 1990, Medicina.

Gastrointestinal endoscopy and HBV infection: no evidence for a causal relationship. A prospective controlled study.

E. Villa, A. Ferrari, C. Pasquinelli, 1984, Gastrointestinal endoscopy.